K Health CEO Allon Bloch: K Health solves the need to make primary care visits highly personalized by giving doctors AI super powers that enable them to practice at the top of their license. AI personalized healthcare startup K Health , which was founded in Israel and operates from Israel and the US, has announced the completion of a $50 million financing round led by Claure Group, with participation from investors including Pablo Legorreta (founder and CEO of Royalty Pharma), and existing investors Mangrove Capital Partners, Valor Equity Partners, and Atreides Management, LP. RELATED ARTICLES AI personalized care co K Health raises $59m This latest financing round is at a valuation of $900 million, "Bloomberg" reports according to people knowledgable on the matter and comes exactly one year after KI Health raised $59 million.
K Health was founded in 2016 by CEO Allon Bloch, Ran Shaul and Israel Roth together with Taboola CEO Adam Singolda. Bloch said, "K Health solves the need to make primary care visits highly personalized by giving doctors AI super powers that enable them to practice at the top of their license. Our primary care platform offers a concierge medical experience, with an assigned provider and 24/7 access to care.
When partnered with leading health systems like Cedars-Sinai, this model creates significant benefits to access, clinical outcomes, and patient experience. All you need to get care is your health insurance, a stark contrast to concierge medicine servi.